A joint project of the Graduate School, Peabody College, and the Jean & Alexander Heard Library

Title page for ETD etd-11192013-140238

Type of Document Dissertation
Author Mergy, Marc Andrew
URN etd-11192013-140238
Title Generation and Characterization of the First Construct-Valid Model of ADHD, the DAT Val559 Knock-In Mouse
Degree PhD
Department Neuroscience
Advisory Committee
Advisor Name Title
Eric Delpire Committee Chair
Randy Blakely Committee Chair
Aurelio Galli Committee Member
Hassane Mchaourab Committee Member
  • transporter
  • dopamine
  • ADHD
  • transgenic
  • mouse
  • animal model
Date of Defense 2013-07-29
Availability unrestricted
Attention-deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed childhood neuropsychiatric disorder. More than twenty years of genetic, behavioral, and pharmacological research support the hypothesis that compromised brain dopamine (DA) signaling impacts risk for the disorder. To date, however, evidence for this idea is indirect, and we therefore lack a construct-valid animal model for ADHD. To gain direct evidence for changes in DA-regulatory molecules in ADHD, we screened subjects with a DSM-IV diagnosis of the disorder and identified multiple, rare DA transporter (DAT, SLC6A3) coding variants. One of these variants, DAT Val559, induces anomalous, non-vesicular DA release in transfected cells, and efflux that can be blocked by the most common ADHD medications, D-amphetamine (AMPH) and methylphenidate. To pursue the significance of these findings in vivo, we engineered DAT Val559 knock-in mice and, as with heterologous expression studies, found the variant to support expression of wild-type (WT) levels of striatal DAT and tyrosine hydroxylase (TH) protein, as well as DA and DA metabolite levels. However, DAT Val559 mice exhibited a novel, conditional hyperactivity phenotype, “darting”, as well as an impaired sensitivity to the locomotor-activating properties of AMPH. In vivo microdialysis studies in the striatum of DAT Val559 animals demonstrated a pronounced elevation of basal, extracellular DA levels along with a significantly blunted efflux of DA release evoked by locally infused AMPH. Together, our studies confirm a functional impact on extracellular DA homeostasis of the DAT Val559 variant in vivo and establish the first construct-valid animal model of ADHD.
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  Mergy.pdf 9.42 Mb 00:43:37 00:22:25 00:19:37 00:09:48 00:00:50

Browse All Available ETDs by ( Author | Department )

If you have more questions or technical problems, please Contact LITS.